Certolizumab Pegol for the Treatment of Patients with Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S3, 2018. DOI: 10.25251/skin.2.supp.3. Disponível em: https://skin.dermsquared.com/skin/article/view/306. Acesso em: 19 apr. 2026.